SYNCOM FORMULATION (INDIA)
Smallcap | BSE
Sector
Index
Here's the live share price of Syncom Formulation (India) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.50₹ 0.71
As on Sep 08, 2026, 04:01 PM IST
Source: Dion Global
Syncom Formulation (India) Price Performance
Today's LowToday's High
₹20.31₹21.50
₹20.98
52 Weeks' Low52 Weeks' High
₹10.21₹22.52
₹20.98
Open Price
₹20.31
Prev. Close
₹20.27
Volume
8,64,759
Source: Dion Global
Syncom Formulation (India) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syncom Formulation (India) | 4.53 | 45.69 | 48.27 | 76.90 | 21.98 | 33.74 | 28.66 |
| Sun Pharmaceutical Industries | -2.56 | -3.67 | 5.17 | 4.07 | 19.03 | 18.49 | 19.34 |
| Divi's Laboratories | 4.42 | 15.66 | 46.87 | 51.03 | 58.82 | 37.33 | 13.47 |
| Torrent Pharmaceuticals | 0.08 | 0.96 | 12.48 | 13.54 | 37.48 | 38.38 | 26.22 |
| Zydus Lifesciences | -1.21 | 2.61 | 5.75 | 26.56 | 13.96 | 22.32 | 15.66 |
| Cipla | -2.40 | -5.21 | -0.31 | 4.44 | -10.21 | 3.63 | 7.77 |
| Laurus Labs | 4.60 | 4.26 | 38.51 | 90.57 | 117.17 | 68.00 | 24.25 |
| Aurobindo Pharma | 0.18 | 2.43 | 16.13 | 35.20 | 62.08 | 25.22 | 17.79 |
| Lupin | -1.77 | -7.16 | -6.24 | -8.24 | 8.47 | 23.23 | 16.55 |
| Dr. Reddy's Laboratories | -1.67 | -0.51 | -9.74 | -10.49 | -7.91 | 1.04 | 3.23 |
| Mankind Pharma | -2.29 | -5.42 | -2.23 | 6.65 | -10.58 | 9.49 | 10.12 |
| Glenmark Pharmaceuticals | 0.53 | 7.90 | 13.72 | 17.03 | 20.69 | 47.22 | 36.64 |
| Biocon | -2.17 | -8.71 | -4.07 | 0.71 | 7.77 | 13.78 | 2.00 |
| Alkem Laboratories | -2.16 | -6.33 | -3.11 | -5.03 | -2.53 | 12.76 | 6.68 |
| Abbott India | -2.32 | -7.33 | -1.02 | -6.00 | -17.59 | 3.54 | 5.01 |
| Anthem Biosciences | 3.88 | 12.38 | 23.98 | 45.30 | 17.53 | 9.50 | 5.60 |
| GlaxoSmithKline Pharmaceuticals | -2.16 | 12.65 | 34.19 | 16.19 | 3.87 | 26.09 | 14.03 |
| Ipca Laboratories | -1.76 | 15.70 | 18.40 | 29.51 | 47.88 | 29.28 | 8.99 |
| Gland Pharma | 3.30 | 11.25 | 31.83 | 76.39 | 58.57 | 20.52 | -5.60 |
| Ajanta Pharma | 2.63 | 2.49 | 21.12 | 22.62 | 39.01 | 27.66 | 20.10 |
Source: Dion Global
Over the last one year, Syncom Formulation (India) has gained 21.98% compared to peers like Sun Pharmaceutical Industries (19.03%), Divi's Laboratories (58.82%), Torrent Pharmaceuticals (37.48%). From a 5 year perspective, Syncom Formulation (India) has outperformed peers relative to Sun Pharmaceutical Industries (19.34%) and Divi's Laboratories (13.47%).
Syncom Formulation (India) Financials
Source: Dion Global
Syncom Formulation (India) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 20.56 | 20.36 |
| 10 | 19.14 | 19.29 |
| 20 | 17.21 | 17.75 |
| 50 | 15.04 | 15.88 |
| 100 | 14.64 | 14.99 |
| 200 | 14.08 | 14.87 |
Source: Dion Global
Syncom Formulation (India) Share Holding Pattern
In the latest quarter, Syncom Formulation (India) remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.35%, and public shareholding moved down to 49.07% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Syncom Formulation (India) Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 08, 2026, 12:36 AM IST IST | Syncom Formul. - Regulation 36(1)(B) Of The SEBI (LODR) Regulations, 2015- Dispatch Of Letters To Shareholders Who Have Not R |
| Sep 08, 2026, 12:23 AM IST IST | Syncom Formul. - Business Responsibility and Sustainability Reporting (BRSR) |
| Sep 08, 2026, 12:16 AM IST IST | Syncom Formul. - Submission Of The Notice Of 38Th Annual General Meeting To Be Held On Wednesday 30Th September, 2026. |
| Sep 08, 2026, 12:09 AM IST IST | Syncom Formul. - Reg. 34 (1) Annual Report. |
| Aug 13, 2026, 11:22 PM IST IST | Syncom Formul. - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015('Listing Regul |
Source: Dion Global
About Syncom Formulation (India)
Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 486.57 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address7, Niraj Industrial Estate, Off Mahakali Caves Road, Mumbai Maharashtra 400093
- Contact
Source: Dion Global
Management
- Mr. Ankit Kedarmal BankdaExecutive Chairman & Whole-time Director
- Mr. Vijay Shankarlal BankdaManaging Director
- Mr. Kedarmal Shankarlal BankdaWhole Time Director
- Mrs. Ruchi JindalIndependent Woman Director
- Mr. Ritesh Kumar LunkadIndependent Director
- Mr. Ankit JainIndependent Director
FAQs on Syncom Formulation (India) Share Price
What is the share price of Syncom Formulation (India)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syncom Formulation (India) is ₹20.98 as on Sep 08, 2026.
What kind of stock is Syncom Formulation (India)?
The Syncom Formulation (India) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Syncom Formulation (India)?
The market cap of Syncom Formulation (India) is ₹1,972.12 Cr as on Sep 08, 2026.
What are today's High and Low prices of Syncom Formulation (India)?
Today’s highest and lowest price of Syncom Formulation (India) are ₹21.50 and ₹20.31.
What are the 52 Week High and 52 Week Low of Syncom Formulation (India)?
The 52-week high/low is the highest and lowest price at which Syncom Formulation (India) stock has traded in the past 52-week or nearly a year. The 52-week high of Syncom Formulation (India) is ₹22.52 and 52-week low of Syncom Formulation (India) is ₹10.21 as on Sep 08, 2026.
How has the Syncom Formulation (India) performed historically in terms of returns?
The Syncom Formulation (India) has shown returns of 3.5% over the past day, 45.69% for the past month, 48.27% over 3 months, 21.98% over 1 year, 33.74% across 3 years, and 28.66% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Syncom Formulation (India)?
P/E ratio of and PB ratio of Syncom Formulation (India) are 23.06 and 4.48 on Sep 08, 2026. While the company gives a dividend yield of 0.48 per annum.
Source: Dion Global
✕